Earningsreport

Q2/2023 6/30/2023 EPS -0.580 ZacksConsensus -0.500 ActVsEst (0.080) - Miss

Actinium Pharmaceuticals, Inc. (Delaware)  (ATNM) 
NASDAQ:AMEX Investor Relations: ir.actiniumpharma.com